Effect of angiotensin‐converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin‐induced diabetic rats
Authors:
- Joffrey ZollJZJoffrey Zoll
- Frederic DaussinFDFrederic Daussin
- Christiane DamgéCDChristiane Damgé
- Pauline HelmsPHPauline Helms
- Sami TalhaSTSami Talha
- Laurence RasseneurLRLaurence Rasseneur
- Francois PiquardFPFrancois Piquard
- Bernard GenyBGBernard Geny
- 24 September 2007
- journal article
- Published by Wiley in Experimental Physiology
- Vol. 92 (6) , 1047-1056
Abstract
Since exercise capacity is related to the mitochondrial respiration rate in skeletal muscle and both parameters are potentially modulated by the onset of diabetes and by inhibition of the angiotensin‐converting enzyme (ACE), we investigated whether skeletal muscle oxidative functions and exercise capacities are impaired in chronic streptozotocin‐induced diabetic (STZ) rats and whether ACE inhibition could reverse such abnormalities. The ACE inhibitor perindopril (2 mg kg−1 day−1) was given for a period of 5 weeks to 7‐month‐old STZ rats (DIA‐PE, n= 8) whose haemodynamic function, skeletal muscle mitochondrial function and exercise capacity were compared with those of untreated diabetic (DIA, n= 8) and control rats (CONT, n= 8). Increased arterial blood pressure (157 ± 12 versus 130 ± 6 mmHg, P < 0.05) and reduced exercise capacity (29 ± 2 versus 91 ± 2 min, respectively, P < 0.01) were observed in DIA compared with CONT. The oxidative capacity of the gastrocnemius muscle was significantly reduced in DIA compared with CONT rats (5.4 ± 0.5 versus 10.6 ± 0.7 μmol O2 min−1(g dry weight)−1, respectively, P < 0.001). Moreover, the coupling between oxidation and phosphorylation was significantly impaired in DIA (−52%, P < 0.001). Angiotensin‐converting enzyme inhibition (ACEi) normalized blood pressure without improving mitochondrial function (4.3 ± 0.8 μmol O2 min−1 (g dry weight)−1 in DIA‐PE rats) but reduced exercise capacity to even lower levels (10 ± 1 min, P < 0.01). Exercise capacity correlated positively with blood pressure in DIA‐PE (r= 0.79, P < 0.05). In experimental type 1 diabetic rats, both skeletal muscle mitochondrial respiration and exercise capacity are impaired. The ACEi failed to restore the muscular function and worsened exercise capacity. Further studies will be useful to determine whether an inadequate muscular blood flow secondary to the reduction in mean systemic blood pressure can explain these results.Keywords
This publication has 51 references indexed in Scilit:
- Defective Mitochondrial BiogenesisCirculation Research, 2007
- Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1αCell, 2006
- ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunctionJournal of Applied Physiology, 2006
- Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetesLife Sciences, 2006
- Exercise capacity in subjects with type 1 diabetes mellitus in eu- and hyperglycaemiaDiabetes/Metabolism Research and Reviews, 2005
- Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitusPediatric Diabetes, 2005
- Concerted action of the renin–angiotensin system, mitochondria, and antioxidant defenses in agingMolecular Aspects of Medicine, 2004
- Enalapril and losartan attenuate mitochondrial dysfunction in aged ratsThe FASEB Journal, 2003
- Physical activity changes the regulation of mitochondrial respiration in human skeletal muscleThe Journal of Physiology, 2002
- Influence of the Degree of Metabolic Control on Physical Fitness in Type I Diabetic AdolescentsInternational Journal of Sports Medicine, 1986